Cat. #162326
Glioblastoma WHO IV spheroid cell line, NCH627
Cat. #: 162326
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Campos et al. 2014. J Pathol. 234(1):23-33. PMID: 24756862.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV spheroid cell line, NCH627
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV spheroid cell line, NCH627
- Biosafety level: 2
Handling
- Growth medium: DMEM-F12 supplemented with BIT100 supplement (Provitro), 2 mM L-glutamine, 30U/ml penicillin-steptomycin, 1U/ml heparin , 20ng/ml bFGF and 20ng/ml EGF
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Campos et al. 2014. J Pathol. 234(1):23-33. PMID: 24756862.
- Dokic et al. 2012. Glia. 60(11):1785-1800. PMID: 22951908.
